49.17 USD
+0.54
1.11%
At close Updated Feb 11, 12:13 PM EST
1 day
1.11%
5 days
3.23%
1 month
3.3%
3 months
-4.88%
6 months
4.15%
Year to date
1.95%
1 year
-8.78%
5 years
3.08%
10 years
28.15%
 

About: Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Employees: 82,878

0
Funds holding %
of 7,556 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™